HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment - Wikidata - wikimedia - TriplyDB

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

http://www.wikidata.org/entity/Q34644242

about

Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals Targeting the Brain Reservoirs: Toward an HIV Cure Analysis of cerebrospinal fluid from chronic fatigue syndrome patients for multiple human ubiquitous viruses and xenotropic murine leukemia-related virus Evolutionary dynamics of HIV at multiple spatial and temporal scales.Relationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis.Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.HIV-associated neurocognitive disorder.Evolving character of chronic central nervous system HIV infection.In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects.Impact of antiretroviral therapy on HIV-related brain injury.Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy.Controversies in HIV-associated neurocognitive disorders Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.HIV eradication symposium: will the brain be left behind?Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF.Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.The cerebrospinal fluid proteome in HIV infection: change associated with disease severity HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy A pilot study of the effects of internet-based cognitive stimulation on neuropsychological function in HIV disease.Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders.Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60.Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells Enhanced antagonism of BST-2 by a neurovirulent SIV envelope Monocyte/macrophages and their role in HIV neuropathogenesis.Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage.Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.Where does HIV hide? A focus on the central nervous system.Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system HIV reservoirs and strategies for eradication.

P2860

Q28073408-E3A938AE-3311-45F3-ABD9-B18FF81E99CE Q28075694-3A082036-9FF5-4872-B699-A56A1464CE25 Q28308258-151F4AEA-43D1-45C7-AF20-24E7E6257B52 Q30416280-1A7416E8-99AA-4AC4-808F-B4560E210A14 Q33609454-CEE1CC25-C067-4E88-8B8B-62D88CEC3571 Q33712027-4CF018A2-6259-460D-B8C7-1EDF33617F04 Q33750994-FBA65346-938C-4325-B8DC-87B7B417AAA9 Q33938797-A04D04F3-749C-4A2A-8D02-E5ED380BF2BF Q33939729-1BB88616-C827-4AD5-9CE6-A74CAFB59E50 Q33995713-BEC145EC-D1BA-4B90-B565-503D4DE80F3C Q34103125-89E3F688-697E-428F-8038-06A9ADE34F3E Q34202181-2A132C26-51C7-44C2-8ACE-AC050BFFD07D Q34699119-EE417508-AF2D-415C-9C1C-B21E13533448 Q34731516-7E2850A6-358B-4A8F-962C-860FE62C4154 Q35037015-4693916A-5F1E-4B91-933B-76E68005657D Q35057044-AE3E5692-6344-497F-827D-18EDCFD45F74 Q35532868-ADFBE6AF-92D8-4FE6-89C1-CE95E8AFF04E Q35606068-A143D870-E0F8-4CDB-9C68-16D66ED77B7C Q35607587-8A6EBBDD-8E56-4918-9265-CCF6D262CF50 Q35677628-2D244CD3-E44F-48BD-AF63-29D6AD05DECB Q35699612-B1F1080B-9AD5-4ECE-8AD5-4405C99712DA Q35822465-D2EEEB20-B0BA-497B-8563-619DB2F26066 Q35965332-80EA5C8A-4F3E-4140-8CE7-19473FBD256A Q36009246-91B59F53-F50F-471B-BADE-5B85CA6ABE16 Q36086223-C9A7BE6A-E16E-490D-85F1-8B19E231B98E Q36089644-66326014-0301-4B62-9A2B-81646EF6EFE3 Q36204440-798ADE05-340C-4B69-A070-B57B8750E9B2 Q36425853-724FD407-67CC-42B9-985E-E594AFC020BE Q36520504-9598921D-9916-4310-A802-60C3414F5BBA Q36551179-B390F4AA-6EB3-45D3-99DC-6A38E1F19C9F Q36559821-5C0FFBE9-16AA-42F3-B6AF-76FF0F872606 Q36951741-E5706AB3-133D-4279-8F5E-DD64A7F49FE0 Q36991666-DA21F62C-9A3E-4077-8997-5D11A8A9C606 Q37116803-7229211B-DE0B-473D-A0DD-50918FD6D4A9 Q37300347-E09A8E6B-C12D-459D-A68C-2D4CE28A2FAC Q37404160-0839C7E1-BD20-456F-9A08-072F98A1754D Q37436136-C64F25F5-9A1D-4358-BA48-F09778E319C7 Q37590425-55C167A4-F6C7-4805-96BB-04559FE1F3E0 Q37592018-327E1601-9635-44E2-81EA-6C5D570A242A Q37976293-37EF589A-AEF4-4B6E-8A44-2FD5A706CD62

P2860

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

http://www.wikidata.org/entity/Q34644242

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@ast

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@en

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@nl

type

label

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@ast

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@en

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@nl

prefLabel

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@ast

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@en

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@nl

P1433

Q34644242-4937A1A5-7368-4C0C-B457-B2A3DDECACBE

P1476

Q34644242-1D2C30FD-A133-47DC-A4BE-E99F9FC5CF02

P2093

Q34644242-1D84D9F8-BBA3-45E6-8839-B63C2F3FE46C

Q34644242-5F67F56B-68D1-40BA-9FC8-708FE506A94F

Q34644242-62150935-CF76-433F-85F8-95EE5E03BA36

Q34644242-6AF954F6-0A69-4CC4-BBF4-95095A5F417B

Q34644242-801A9D2E-A488-4A45-B1CF-C451601E2804

Q34644242-820983AD-33FE-4CB1-AEF4-228FF3B1E2B5

Q34644242-FFFB6039-6DF9-4108-9C67-D306E4805FFF

P2860

Q34644242-0BB3194C-00C0-49CC-9BDE-E41F30A54B4A

Q34644242-18F952D9-5C06-44C8-B404-8A50280DF322

Q34644242-194990C4-2E80-4A52-80DE-2196664776E9

Q34644242-1A9ECA00-BFE7-4F17-89AB-1BA370571F7A

Q34644242-2B6F2128-7795-4738-98DE-8EAE75FE43D4

Q34644242-3F3277C2-786D-4360-8189-886F450A3856

Q34644242-455AC037-FFBF-46EF-B959-2F716113BCD5

Q34644242-4CCD9420-E564-4DE6-BA19-C8EF2BC20457

Q34644242-502A4372-49DD-40E5-89D1-2F0C5801E527

Q34644242-57D18F57-250D-496E-AFB1-18D2C352AFBC

P304

Q34644242-CF72C911-2714-428C-AA53-99E42DF6BB09

P31

Q34644242-BF6DBA92-8BBA-4EA9-9149-7915483B01F6

P356

Q34644242-43AA5670-E663-40B3-ACB5-35B69D4433F9

P407

Q34644242-6402607B-9C82-425D-9D11-ECB9C707BA4F

P433

Q34644242-DE391D14-1260-49FF-BF4B-65F3021353C3

P478

Q34644242-0D3C13E6-9D96-4776-9BAB-60CBBEDF115F

P50

Q34644242-78548F30-2F53-438B-919A-8F9D9912446A

P577

Q34644242-16D7531C-1C33-4B2F-A7D3-C128D4FB6197

P5875

Q34644242-4188A5CB-8EB8-4541-94CC-7140A7B12BB5

P698

Q34644242-297731CE-0445-40DB-A423-7CA20568EFDA

P921

Q34644242-22A827FC-C097-4DF9-B59F-7785A1FFB808

Q34644242-6EF2008F-39AD-466C-9F97-D1560A43A1A3

P932

Q34644242-A5F2AC0A-3A70-453B-8457-AC5755587068

P356

P1433

The Journal of Infectious Diseases

P1476

HIV-1 viral escape in cerebros ...... ssive antiretroviral treatment

@en

P2093

Arvid Edén

http://www.w3.org/2001/XMLSchema#string

Bo Svennerholm

http://www.w3.org/2001/XMLSchema#string

Dietmar Fuchs

http://www.w3.org/2001/XMLSchema#string

Lars Hagberg

http://www.w3.org/2001/XMLSchema#string

Magnus Gisslén

http://www.w3.org/2001/XMLSchema#string

Richard W Price

http://www.w3.org/2001/XMLSchema#string

Serena Spudich

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

CD4+ count-guided interruption of antiretroviral treatment

Updated research nosology for HIV-associated neurocognitive disorders

Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.

Treatment of HIV infection: Swedish recommendations 2009.

P304

1819-1825

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/657342

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

Staffan Nilsson

P577

2010-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47677750

http://www.w3.org/2001/XMLSchema#string

P698

21050119

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

antiretroviral drug

P932

3052942

http://www.w3.org/2001/XMLSchema#string